Dr Reddys Laboratories (RDY) Other Non Operating Income (2014 - 2026)
Dr Reddys Laboratories (RDY) recorded quarterly Other Non Operating Income of -$37.7 million in Q1 2026, down 335.84% quarter-over-quarter from -$8.6 million in Q4 2025, and down 32.39% on a YoY basis from -$55.7 million in Q1 2025.
Dr Reddys Laboratories (RDY) Other Non Operating Income (2014 - 2026) Analysis & Trends
Dr Reddys Laboratories' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$37.7 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 32.39% year-over-year to -$37.7 million; the TTM figure through Mar 2026 stood at -$52.3 million (down 2.51% YoY), while the FY2026 annual figure was -$6.0 million, up 88.38% from the prior year.
- Other Non Operating Income was -$37.7 million for Q1 2026 at Dr Reddys Laboratories, down from -$8.6 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $36.2 million in Q1 2024 to a low of -$78.1 million in Q2 2022.
- Historically, Other Non Operating Income has averaged -$9.6 million across 5 years, with a median of -$8.6 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income sank 17808564.02% in 2022, then jumped 1159.96% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $8.9 million in 2022, then slumped by 230.26% to -$11.6 million in 2023, then jumped by 55.23% to -$5.2 million in 2024, then slumped by 66.3% to -$8.6 million in 2025, then plunged by 335.84% to -$37.7 million in 2026.
- The last three Other Non Operating Income figures came in at -$37.7 million (Q1 2026), -$8.6 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.69 Mn |
| Dec 31, 2025 | -8.65 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | -8.64 Mn |
| Mar 31, 2025 | -28.47 Mn |
| Dec 31, 2024 | -5.20 Mn |
| Sep 30, 2024 | -11.75 Mn |
| Jun 30, 2024 | -5.63 Mn |
| Mar 31, 2024 | 36.23 Mn |
| Dec 31, 2023 | -11.61 Mn |
| Sep 30, 2023 | -21.73 Mn |
| Jun 30, 2023 | -9.49 Mn |
| Mar 31, 2023 | -3.42 Mn |
| Dec 31, 2022 | 8.92 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -78.12 Mn |
| Mar 31, 2022 | 22.77 Mn |
| Dec 31, 2021 | -3.20 Mn |
| Sep 30, 2021 | -23.52 |
| Jun 30, 2021 | -6.60 Mn |